Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
Xencor, Inc.
Xencor, Inc.
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins